Skip to content
Screener

Reported August 6, 2025 · After market close

Revenue$79.2MMiss by $5.2M
EPS-$0.35Beat by $0.06
Revenue estimate$84.3M
EPS estimate-$0.41

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$101.1M
EPS estimate-$0.39

Financials

Q2 2025

Income statement

See full
Revenue$79.2M+48.4%
Gross profit$51.7M+64.4%
Operating income-$22.2M+17.3%
Net income-$19.6M+23.6%
EPS (diluted)-$0.35+30.0%

Balance sheet

See full
Cash & equivalents$305.8M+40.8%
Total debt$79.4M-2.0%
Total equity$385.8M+53.2%
Total assets$513.1M+37.1%

Cash flow

See full
Operating cash flow-$15.0M+4.4%
CapEx$2.8M+169%
Free cash flow-$17.8M-6.4%

Valuation & ratios

Profitability

See full
Gross margin64.2%+9.5pp
Operating margin-33.4%-10.6pp
Net margin-30.6%-9.9pp
FCF margin-32.5%-10.5pp

Returns & leverage

See full
Return on equity-26.4%-8.6pp
Debt / equity0.2×-0.1×
Current ratio9.2×+1.7×

Segments

By product

See full
Handpieces and other consumables$49.1M+66.4%
Service$5.0M+71.7%

FAQ

When did PROCEPT BioRobotics Corporation report Q2 2025 earnings?
PROCEPT BioRobotics Corporation (PRCT) reported Q2 2025 earnings on August 6, 2025 after market close.
What were PROCEPT BioRobotics Corporation's Q2 2025 revenue and EPS?
PROCEPT BioRobotics Corporation reported revenue of $79.2M and eps of $-0.35 for Q2 2025.
Did PROCEPT BioRobotics Corporation beat estimates in Q2 2025?
Revenue missed the consensus estimate of $84.3M by $5.2M. EPS beat the consensus estimate of $-0.41 by $0.06.
How did PROCEPT BioRobotics Corporation's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 48.4% from $53.4M a year earlier and eps grew 30.0% from $-0.50.
Where can I find PROCEPT BioRobotics Corporation's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001588978-25-000041) and the 10-Q periodic report (0001588978-25-000043) directly on SEC EDGAR. The filing index links above go to sec.gov.